The growth of the market is driven by factors such as the rising prevalence of cancer and the increasing adoption of digital pathology in developed economies. However, the market is likely to have a negative impact due to a lack of skilled professionals.
Cancer is one of the significant causes of death across the globe, and its increasing prevalence is boosting the number of histopathology tests. A tissue pathology analysis is needed for the examination of a malignant tumour to predict the onset of cancer. According to data reported in the American Cancer Society, expected 1,762,450 cancers were diagnosed in 2019, which comprises more than 4,800 new cases per day in the US. Moreover, 103,250 cancer deaths were recorded among the older group in 2019, accounting for 17% of all cancer deaths in the country. Increasing rates of cancer and growing knowledge concerning early diagnostic procedures are expected to boost the adoption rate of microtomes throughout the forecast period. Examination of biopsy tissues helps pathologists in discovering cancer type, stage, and the degree of disease spread.
Request For Sample Reports @ https://www.theinsightpartners.com/sample/TIPRE00013018/
Moreover, increasing awareness programs initiated by organizations such as World Health Organization (WHO), National Cervical Cancer Coalition, and the Centers for Disease Control and Prevention (CDC) for cancer screening are further driving the market growth. For example, the National Breast and Cervical Cancer Early Detection Program (NBCCEDP) of CDC have granted uninsured, low-income, and underserved women access to appropriate breast and cervical cancer screening and diagnostic services. The factors mentioned above are expected to drive the growth of the market for microtome during the coming years.
Furthermore, the impact of the COVID-19 pandemic on cancer patients, surgical cases, and others is high in terms of the maintenance of surgical wounds. The companies in the microtome and its associated accessories market are facing issues in keeping their production facilities fully functional due to a shortage of staff and resources amidst the COVID-19 outbreak. Drug discovery and manufacturing is the most crucial part of the development of new therapeutics. Since the surge of COVID-19 cases, the pharmaceutical industry is facing a decrease in production capabilities. Although all regular surgeries in countries with COVID-19 disease have been halted during the pandemic era, the requirement for coordinated emergency care delivered by teams with appropriate personal protective equipment takes precedence.
North America Microtome Market– Market Segmentation
By End User
You Can Buy This Report from Here@ https://www.theinsightpartners.com/buy/TIPRE00013018/
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.
Smart Market News brings you the stories of adopting innovative solutions and strategies that have been changing the world. Our insights on products, solutions, companies, and adoption of best practices help in understanding the markets better and make smarter decisions.
Smarter Decisions with Smart News
Smart Market News is committed to getting its readers the latest updates and insights on industries that help in making “smarter” business decisions. With insights and inputs from corporate decision makers, we bring you the stories of adopting innovative solutions and strategies that have been changing the world. Our editorial insights on products, solutions, companies, and adoption of best practices not only help in understanding the markets better, but also prove to be a complete package for your information needs.